• Actuate Therapeutics named Martin Huber, MD, to its board of directors.
• Huber is a board member at Syndax Pharmaceuticals.
• He most recently served as president and CEO of Mersana Therapeutics until its acquisition by Day One Pharmaceuticals in January 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actuate Therapeutics Inc. published the original content used to generate this news brief on May 11, 2026, and is solely responsible for the information contained therein.